Skip to content

RA Capital Nexus Fund III, L.P., Director at Artiva Biotherapeutics, bought ARTV on Jul 23, 2026

Data as of Oct 16

▲ BUY$596K59,880 shares at $9.96RA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.
Watch ARTV
Traded
Jul 23, 2026
Disclosed
Jul 23, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

RA Capital Nexus Fund III, L.P., Director at Artiva Biotherapeutics, bought ARTV on Jul 23, 2026TRADEDDISCLOSED
ARTVSimilar stocks (XLV — its sector index fund), rebased to ARTV's price on the disclosure day
ARTV since disclosure
−42.3%
Similar stocks (XLV) since disclosure
+9.5%
XLV — its sector index fund

Change in closing price from Jul 23, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$596Kdisclosed Jul 23 · filed the same day
  2. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$596Kdisclosed Jul 23 · filed the same day
  3. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$596Kdisclosed Jul 23 · filed the same day
  4. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$596Kdisclosed Jul 23 · filed the same day
  5. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$596Kdisclosed Jul 23 · filed the same day
  6. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  7. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  8. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  9. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  10. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  11. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  12. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
  13. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
  14. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
  15. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade

See every trade on ARTV →